| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 189.294 | 228.001 | 233.846 | 231.858 | 225.631 | 193.038 | 246.900 | 322.243 | 310.495 | 448.177 |
| Total Income - EUR | 191.317 | 229.451 | 238.686 | 237.576 | 225.865 | 193.425 | 246.935 | 325.864 | 310.604 | 448.178 |
| Total Expenses - EUR | 195.625 | 215.409 | 225.524 | 234.805 | 215.547 | 203.132 | 243.841 | 316.288 | 302.783 | 411.634 |
| Gross Profit/Loss - EUR | -4.308 | 14.042 | 13.162 | 2.772 | 10.317 | -9.707 | 3.094 | 9.577 | 7.821 | 36.544 |
| Net Profit/Loss - EUR | -4.308 | 14.042 | 10.180 | 404 | 8.059 | -11.641 | 625 | 6.318 | 4.774 | 31.036 |
| Employees | 5 | 6 | 6 | 0 | 6 | 6 | 7 | 7 | 6 | 8 |
Check the financial reports for the company - Amedeea Is Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.628 | 5.145 | 19.875 | 11.192 | 7.172 | 3.710 | 3.856 | 2.029 | 1.834 | 2.195 |
| Current Assets | 24.504 | 27.811 | 50.099 | 72.359 | 41.363 | 42.288 | 81.091 | 88.372 | 74.531 | 127.093 |
| Inventories | 17.031 | 26.410 | 33.790 | 43.120 | 30.827 | 29.676 | 35.802 | 23.632 | 22.637 | 56.571 |
| Receivables | 6.381 | 0 | 2.354 | 1.774 | 3.420 | 3.455 | 32.002 | 54.853 | 37.827 | 61.048 |
| Cash | 1.092 | 1.401 | 13.955 | 27.396 | 6.702 | 8.789 | 12.399 | 8.392 | 9.682 | 7.768 |
| Shareholders Funds | -20.384 | -6.134 | 4.149 | 449 | 8.103 | -11.573 | -10.691 | -4.406 | 381 | 31.415 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 57.807 | 45.817 | 75.973 | 96.459 | 68.406 | 77.681 | 115.303 | 114.534 | 102.230 | 123.972 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Amedeea Is Pharm Srl